My watch list
my.bionity.com  
Login  

875 Current news from the ressort finances

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

Merck Generates Profitable Growth in Q3 2019

15-Nov-2019

Merck generated strong organic sales growth and benefited from positive foreign exchange effects in the third quarter of 2019. EBITDA pre increased even more strongly than net sales in the three-month period from July to September. Following the closing of the Versum Materials (Versum) ...

more

image description
Bayer invests USD 50 Million in eGenesis Series B financing round

Investment to support development of human-compatible xeno organs to address the global organ shortage crisis

11-Nov-2019

eGenesis, a biotechnology company utilizing breakthrough gene editing technologies for the development of effective human-compatible organs to address the global organ shortage, successfully completed a USD 100 million Series B financing. The financing was led by Fresenius Medical Care Ventures ...

more

Bayer: Encouraging business performance across all divisions

Agreements signed to divest Currenta and Animal Health

30-Oct-2019

Bayer has made progress in all key areas and is on track both operationally and strategically. “Bayer had a successful third quarter,” Werner Baumann, Chairman of the Board of Management, said on Wednesday during the news conference call on the quarterly figures. “We increased the Group’s sales ...

more

image description
Genomic methods and big-data to contain the illegal animal trade

Ark-Biodiversity and HTGF have completed the first joint financing round

29-Oct-2019

Ark-Biodiversity is the newest foundation of the serial entrepreneur Alexander Olek. The 50-year-old father of four children says: “I don’t believe in the survival of humanity without biodiversity; and I do not believe in the conservation of biodiversity, unless our societies find joint ...

more

Sartorius continues on its dynamic growth track

21-Oct-2019

Sartorius performed dynamically in the third quarter as well, achieving double-digit growth rates in sales revenue, order intake and earnings in the first nine months. “Sartorius achieved significant double-digit growth rates in sales revenue and earnings for the first nine months of the year as ...

more

image description
€12M Series A Financing to Develop Novel Immuno-Virotherapies Against Cancer

17-Oct-2019

Abalos Therapeutics announced a EUR 12 million Series A financing round establishing its operations and leadership. The Company’s objective is to develop new immuno-oncology therapeutics based on a specific arenavirus strain that preferentially infects and proliferates in cancer cells generating ...

more

Create blood vessels using patient’s own cells

Vacis raises capital from Brightlands Venture Partners, HTGF, LIOF and RVO

14-Oct-2019

Every year, an estimated 300.000 hemodialysis patients worldwide die as they run out of medical alternatives. One of the main reasons for these deaths is failure of the vascular access site, the blood vessel where blood is removed, filtered and returned to the body during dialysis. To solve this ...

more

image description
€7 Million to Generate First in Class Anti-TACA Antibodies for Cancer Treatment

26-Sep-2019

Tacalyx, a biotech company focused on the discovery and development of novel anti-TACA (Tumor Associated Carbohydrate Antigens) cancer therapies, announced that it has successfully secured €7 million in seed funding. The funding round involves a syndicate of leading European life science and ...

more

image description
Chemistry-for-Healthcare Start-up secures seed investment

18-Sep-2019

Belyntic, a Berlin-based chemistry-for-healthcare startup and developer of the Peptide Easy Clean (PEC) purification technology, has completed its seed financing round amounting to €1.3 million. The funding is led by the Investitionsbank Berlin (IBB), with the High-Tech Gründerfonds (HTGF) also ...

more

Investment Plan for Europe: Successful launch of Tech Transfer Fund “KHAN-I”

13-Sep-2019

Khanu Management GmbH (Khanu), a drug discovery focused fund management team, announces the successful launch of KHAN Technology Transfer Fund I GmbH & Co KG (KHAN-I), based in Dortmund, Germany. The European Investment Fund (EIF, Luxemburg), the Austria Wirtschaftsservice GmbH (Vienna, Austria) ...

more

Page 1 From 88
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE